Bausch & Lomb's Acquisition

Bausch & Lomb was acquired by Valeant Pharmaceuticals International on November 20, 2013.

Bausch & Lomb (NYSE:BHC) (TSX:BHC) is an eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight. Its core businesses include ophthalmic pharmaceuticals, co…

Articles about Bausch & Lomb's Acquisition: